The presentation outlines Myanmar’s policy shift from a two-dose to a single-dose HPV vaccination schedule, driven by operational challenges during COVID-19, missed cohorts, and WHO’s updated recommendations. NITAG adopted a systematic, evidence-based approach using PICO criteria to guide decision-making, ensuring transparency and technical rigor. The revised strategy targets 9–11-year-old girls through school and community campaigns, […]
Format: Presentation
HPV vaccination programme update
Bangladesh’s HPV vaccination campaign, launched in October 2023, began in Dhaka and expanded nationwide by October 2024, targeting girls aged 10–14. Registration through the VaxEPI system reached 5.6 million, with 4.8 million vaccinated—around 90% coverage. Key challenges included data gaps, birth registration barriers, underserved out‑of‑school populations, and vaccine hesitancy driven by misinformation. Field experience highlighted […]
Nepal – National introduction of HPV vaccination, including monitoring
Nepal’s HPV vaccination campaign, launched on 4 February 2025, targeted 1.6 million girls (grades 6–10 and out‑of‑school girls aged 10–14), achieving 94% coverage with single‑dose Cecolin. The program utilized 18,900 schools and 8,200 health facilities, with 51,483 female community health volunteers and 27,000 health workers mobilized. Youth‑led advocacy, child clubs, and digital social listening strategies […]
Country presentation: challenges for scale-up to the National level – Philippines
The Philippines’ HPV vaccination program began as a community-based pilot in 2013 and expanded to school-based delivery by 2015, targeting grade 4 pupils aged 9–14. Coverage initially reached 80%+ but dropped sharply after 2017 due to vaccine controversies and further during COVID-19 when services shifted back to community delivery. Key challenges include high vaccine cost […]
Country presentation: challenges for scale-up to the National level – China
China has not yet integrated HPV vaccination into its national immunization program, though several provinces and cities have launched locally funded or philanthropic initiatives targeting girls aged 12–15. Coverage remains low at 4% by 2022, despite over 85 million doses administered since 2017. The facility‑based strategy relies on strong collaboration between health, education, and finance […]
China: Roadmap to national introduction
China’s HPV vaccination landscape has significantly advanced with the recent approval of the first domestically produced nine-valent vaccine, Cecolin-9, in 2025. Alongside this, expanded indications now allow HPV vaccination for males aged 9–26. The country currently has multiple licensed vaccines, including domestic bivalent and imported quadrivalent and nine-valent options, ensuring broad supply capacity. By May […]
Regional overview: Cervical cancer epidemiology and HPV vaccination progress; Western Pacific Regional Overview
The presentation outlined HPV vaccination progress in the Western Pacific, where 30 of 37 countries have introduced the vaccine, though coverage remains low at 17–35% (2022–2023). Major gaps persist in nations like China, Papua New Guinea, and Vietnam, while Mongolia is planning introduction this year. Most programs target girls only and still use two- or […]
Regional overview: Cervical cancer epidemiology and HPV vaccination progress; SEARO regional overview
HPV vaccination in the WHO South-East Asia Region covers eight of eleven countries, with seven implementing nationwide programs and a growing shift toward single-dose schedules for efficiency. Despite Bhutan’s consistently high coverage and recent scale-ups in Indonesia and Myanmar, regional coverage remains well below the 90% target, with significant gaps in India and Nepal. Constraints […]
UNICEF work on social mobilization, demand generation and communication
Michelle Dynes (UNICEF) presented findings from the 2024 U-Report poll on adolescent awareness and demand for HPV vaccination, involving over 417,000 respondents from 189 countries. Results showed only 24% global awareness (29% in East Asia–Pacific), with most unvaccinated youth expressing willingness but citing barriers such as cost, limited availability, and safety concerns—particularly fear of side […]
DFAT Australia Funding Options
Australia’s National Centre for Immunisation Research presented its role in supporting HPV vaccine scale‑up and cervical cancer elimination across the Indo‑Pacific. Backed by the AUD 620 million “Partnerships for a Healthy Region” program, Australia collaborates with 18 countries on immunisation system strengthening, multi‑age cohorts, and policy support. Two major initiatives were highlighted: the Australian Regional […]